Science Explorer Back to mapMap
Discussion
Company · Rennes · France

Cherry Biotech (France)

Research works
11
▼ 24% vs 2018-21
Citations
76
6.6 per fractional work
Top-10% rate
13.1%
all institutions 10.0%
Open access
58%
world 40%
International
20%
world 18%

Not ranked overall: Cherry Biotech (France) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Cherry Biotech (France) work in?

In all years, 47% of research at Cherry Biotech (France) is in Physical Sciences, 35% in Life Sciences. Its largest fields are Engineering (39%), Biochemistry, Genetics and Molecular Biology (21%), Medicine (17%). It does 1.5× the world's share of Life Sciences.

Physical Sciences: 5 fractional works · 47.2% of its workEngineering: 4 fractional works · 39.1% of its workBiomedical Engineering: 4 fractional works · 34.7% of its workElectrical and Electronic Engineering: 0 fractional works · 2.8% of its workMedia Technology: 0 fractional works · 1.5% of its workAerospace Engineering: 0 fractional works · 0.3% of its workEnvironmental Science: 1 fractional works · 5.9% of its workEcology: 1 fractional works · 5.9% of its workPhysics and Astronomy: 0 fractional works · 2.2% of its workAtomic and Molecular Physics, and Optics: 0 fractional works · 1.5% of its workCondensed Matter Physics: 0 fractional works · 0.7% of its workLife Sciences: 4 fractional works · 35.2% of its workBiochemistry, Genetics and Molecular Biology: 2 fractional works · 20.7% of its workMolecular Biology: 2 fractional works · 18.5% of its workBiophysics: 0 fractional works · 2.2% of its workNeuroscience: 1 fractional works · 8.4% of its workCellular and Molecular Neuroscience: 1 fractional works · 8.4% of its workAgricultural and Biological Sciences: 0 fractional works · 4.0% of its workFood Science: 0 fractional works · 2.9% of its workInsect Science: 0 fractional works · 0.8% of its workPlant Science: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workImmunology and Microbiology: 0 fractional works · 2.1% of its workImmunology: 0 fractional works · 2.1% of its workHealth Sciences: 2 fractional works · 16.5% of its workMedicine: 2 fractional works · 16.5% of its workComplementary and alternative medicine: 1 fractional works · 7.2% of its workPharmacology: 1 fractional works · 7.2% of its workOncology: 0 fractional works · 0.7% of its workHepatology: 0 fractional works · 0.3% of its workImmunology and Allergy: 0 fractional works · 0.3% of its workOphthalmology: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.3% of its workSocial Sciences: 0 fractional works · 1.1% of its workPsychology: 0 fractional works · 0.6% of its workSocial Psychology: 0 fractional works · 0.6% of its workEconomics, Econometrics and Finance: 0 fractional works · 0.3% of its workEconomics and Econometrics: 0 fractional works · 0.3% of its workSocial Sciences: 0 fractional works · 0.3% of its workPolitical Science and International Relations: 0 fractional works · 0.3% of its workALL ITS WORKCherry Biotech(France)11fractional works, all years
Life Sciences35%Physical Sciences47%Health Sciences17%Social Sciences1%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 11 fields, with their numbers
    1. Engineering439.1%
    2. Environmental Science15.9%
    3. Physics and Astronomy02.2%
    1. Biochemistry, Genetics and Molecular Biology220.7%
    2. Neuroscience18.4%
    3. Agricultural and Biological Sciences04.0%
    4. Immunology and Microbiology02.1%
    1. Medicine216.5%
    1. Psychology00.6%
    2. Economics, Econometrics and Finance00.3%
    3. Social Sciences00.3%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.73× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 2.97× its world share, 1 worksBiochemistry, Geneti…Neuroscience: 10.94× its world share, 1 worksNeuroscienceEngineering: 3.91× its world share, 2 worksEngineeringMedicine: 0.12× its world share, 0 worksMedicinePsychology: 0.62× its world share, 0 worksPsychology1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Neuroscience, 10.9×. Every wedge is a field page.

All 6 fields, with their numbers
  1. Neuroscience10.94×1 works
  2. Engineering3.91×2 works
  3. Biochemistry, Genetics and Molecular Biology2.97×1 works
  4. Agricultural and Biological Sciences0.73×0 works
  5. Psychology0.62×0 works
  6. Medicine0.12×0 works

Who are the top researchers at Cherry Biotech (France)?

Ranked on the quality score, J. Cramer lead among researchers whose main affiliation is Cherry Biotech (France).

  1. 1 J. Cramer France · #1,305,512 worldwide 1.1k citations · 19 works
All ranked researchers at Cherry Biotech (France)

What are the most cited papers from Cherry Biotech (France)?

The most cited paper from Cherry Biotech (France) is "Ultrafast, sensitive and large-volume on-chip real-time PCR for the molecular diagnosis of bacterial and viral infections" (Timothée Houssin, J. Cramer, Rébecca Grojsman et al., 2016), with 78 citations. Next come "Expression of TAM-R in Human Immune Cells and Unique Regulatory Function of MerTK in IL-10 Production by Tolerogenic DC" (44) and "Generation and Genetic Engineering of Human Induced Pluripotent Stem Cells Using Designed Zinc Finger Nucleases" (44).

Most cited papers
#PaperReleasedCitations
1 Ultrafast, sensitive and large-volume on-chip real-time PCR for the molecular diagnosis of bacterial and viral infections Timothée Houssin, J. Cramer, Rébecca Grojsman et al. · Lab on a Chip 2016 78
2 Expression of TAM-R in Human Immune Cells and Unique Regulatory Function of MerTK in IL-10 Production by Tolerogenic DC P Giroud, Sarah Renaudineau, Laura Gudefin et al. · Frontiers in Immunology Open access 25 Sep 2020 44
3 Generation and Genetic Engineering of Human Induced Pluripotent Stem Cells Using Designed Zinc Finger Nucleases Sivaprakash Ramalingam, Viktoriya London, Karthikeyan Kandavelou et al. · Stem Cells and Development Open access 30 Aug 2012 44
4 TYRO3 as a molecular target for growth inhibition and apoptosis induction in bladder cancer Florent Dufour, Linda Silina, Hélène Neyret‐Kahn et al. · British Journal of Cancer Open access 15 Feb 2019 35
5 Environmentally Controlled Microfluidic System Enabling Immune Cell Flow and Activation in an Endothelialised Skin‐On‐Chip Elisabetta Michielon, Matteo Boninsegna, Taco Waaijman et al. · Advanced Healthcare Materials Open access 6 Oct 2024 27
All 21 most cited papers, with filters and sorting

Which research topics does Cherry Biotech (France) publish most on?

By volume in 2022-now: 3D Printing in Biomedical Research, Microfluidic and Bio-sensing Technologies, Neuroscience and Neural Engineering and Gut microbiota and health.

  1. 1 3D Printing in Biomedical Research Biomedical Engineering 1 works
  2. 2 Microfluidic and Bio-sensing Technologies Biomedical Engineering 1 works
  3. 3 Neuroscience and Neural Engineering Cellular and Molecular Neuroscience 1 works
  4. 4 Gut microbiota and health Molecular Biology 0 works
  5. 5 Cell Image Analysis Techniques Biophysics 0 works
  6. 6 Image Processing Techniques and Applications Media Technology 0 works
  7. 7 Neurobiology and Insect Physiology Research Cellular and Molecular Neuroscience 0 works
  8. 8 Animal and Plant Science Education Social Psychology 0 works
  9. 9 Insect Utilization and Effects Insect Science 0 works
  10. 10 Planarian Biology and Electrostimulation Molecular Biology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available57.7%not open42.3%

World: 40% of research is openly available.

with international co-authors20.2%domestic only79.8%

World: 18% is written across borders.

How has Cherry Biotech (France)'s research output changed?

Output in 2022-2025 was 24% lower than in 2018-2021.

still counting201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Cherry Biotech (France) as a percentage of every work published that year, 0.000013% in 2024.

still counting0.000020%0.000040%0.000060%Cherry Biotech (France)0.0000095% in 20252020

Fractional works of Cherry Biotech (France) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Rennes

All research institutions in Rennes

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Cherry Biotech (France). Posts are plain text and can be reported.